Mark Heinen - Jun 24, 2022 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Head of Finance and interim Chief Financial Officer
Signature
/s/ Mark Heinen
Stock symbol
BTTX
Transactions as of
Jun 24, 2022
Transactions value $
$4,000
Form type
4
Date filed
6/28/2022, 04:24 PM
Previous filing
Jun 10, 2022
Next filing
Sep 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $4K +2.28K $1.75 2.28K Jun 24, 2022 By daughter F1
holding BTTX Common Stock 20K Jun 24, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.7539 to $1.7576, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Remarks:

Head of Finance and interim Chief Financial Officer